Literature DB >> 23687410

Relationships of CDXs and apical sodium-dependent bile acid transporter in Barrett's esophagus.

Jingbo Zhao1, Hans Gregersen.   

Abstract

Barrett's esophagus (BE) is characterized by intestinal metaplasia with the differentiated epithelium replaced by another type of epithelium morphologically similar to normal intestinal epithelium. The metaplasia is preceded by bile and acid reflux into the esophagus. BE is a premalignant condition associated with increased risk of esophageal cancer, especially esophageal adenocarcinoma. The Caudal-related homeodomain transcription factors Caudal-related homeodomain transcription factor CDX1 and CDX2 are expressed exclusively in the small and large intestine, playing important roles in proliferation and differentiation of intestinal epithelial cells. Ectopic expression of CDX1 and CDX2 occurs in BE. The apical sodium-dependent bile acid transporter (ASBT) is expressed primarily in terminal ileum where it is a key factor for intestinal reabsorption of bile salts. In addition to upregulation of CDX1 and CDX2, ASBT expression is up-regulated in BE. Furthermore, both CDX1/CDX2 and ASBT expressions are down-regulated in high-grade esophageal dysplasia. The alteration of the above-mentioned factors calls for attention: what is the relationship between CDXs and ASBT aberrant expression in BE? In this commentary, we discuss this issue on basis of the recent study done by Ma et al.

Entities:  

Keywords:  Aberrant expression; Apical sodium-dependent bile acid transporter; Caudal-related homeodomain transcription factors; Esophagus; Intestinal metaplasia

Mesh:

Substances:

Year:  2013        PMID: 23687410      PMCID: PMC3653147          DOI: 10.3748/wjg.v19.i18.2736

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

Review 1.  Is there publication bias in the reporting of cancer risk in Barrett's esophagus?

Authors:  N J Shaheen; M A Crosby; E M Bozymski; R S Sandler
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

Review 2.  Focus on Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Thomas G Paulson; Brian J Reid
Journal:  Cancer Cell       Date:  2004-07       Impact factor: 31.743

3.  CDX1 protein expression in normal, metaplastic, and neoplastic human alimentary tract epithelium.

Authors:  D G Silberg; E E Furth; J K Taylor; T Schuck; T Chiou; P G Traber
Journal:  Gastroenterology       Date:  1997-08       Impact factor: 22.682

Review 4.  Intestinal bile acid transport: biology, physiology, and pathophysiology.

Authors:  B L Shneider
Journal:  J Pediatr Gastroenterol Nutr       Date:  2001-04       Impact factor: 2.839

5.  Cdx1 and cdx2 expression during intestinal development.

Authors:  D G Silberg; G P Swain; E R Suh; P G Traber
Journal:  Gastroenterology       Date:  2000-10       Impact factor: 22.682

6.  CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas.

Authors:  Robert W Werling; Hadi Yaziji; Carlos E Bacchi; Allen M Gown
Journal:  Am J Surg Pathol       Date:  2003-03       Impact factor: 6.394

7.  Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.

Authors:  Roy W Phillips; Henry F Frierson; Christopher A Moskaluk
Journal:  Am J Surg Pathol       Date:  2003-11       Impact factor: 6.394

Review 8.  Hallmarks of cancer progression in Barrett's oesophagus.

Authors:  Carmela P Morales; Rhonda F Souza; Stuart J Spechler
Journal:  Lancet       Date:  2002-11-16       Impact factor: 79.321

9.  Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays.

Authors:  Christopher A Moskaluk; Hong Zhang; Steven M Powell; Lisa A Cerilli; Garret M Hampton; Henry F Frierson
Journal:  Mod Pathol       Date:  2003-09       Impact factor: 7.842

10.  Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett's) metaplasia.

Authors:  Gabriel M Groisman; Mary Amar; Alona Meir
Journal:  Mod Pathol       Date:  2004-10       Impact factor: 7.842

View more
  3 in total

1.  Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation.

Authors:  Lin-Hai Yan; Xiao-Tong Wang; Jie Yang; Chao Lian; Fan-Biao Kong; Wei-Yuan Wei; Wen Luo; Qiang Xiao; Yu-Bo Xie
Journal:  World J Gastroenterol       Date:  2013-07-14       Impact factor: 5.742

Review 2.  New insights into the functions and localization of the homeotic gene CDX2 in gastric cancer.

Authors:  Lin-Hai Yan; Wei-Yuan Wei; Yu-Bo Xie; Qiang Xiao
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

Review 3.  Proton Pump Inhibitors: The Culprit for Barrett's Esophagus?

Authors:  Omran Alsalahi; Anca D Dobrian
Journal:  Front Oncol       Date:  2015-01-09       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.